Fig. 4. Distribution of the reported HBV and HCV test results generated using the Cobas TaqMan system within a recent 5-yr period (2018–2022). (A) Regarding HBV, 0.4% of the patients had concentrations of 20–22 IU/mL. (B) Regarding HCV, 0.4% of the patients had concentrations of 15–34 IU/mL.
Abbreviations: HBV, hepatitis B virus; HCV, hepatitis C virus.

Ann Lab Med 2024;44:253~261 https://doi.org/10.3343/alm.2023.0306